Incredibly grateful for @james_paulad's mentorship with this project on vascular abnormalities in patients with von Willebrand disease. Also couldn't have done it without Maaz Shanjer and all his hard work! @queensuim onlinelibrary.wiley.com/doi/10.1111/jt…

I spy two familiar faces 🩸 awesome work Nicole Relke and Nick Chornenki, MD 🇺🇦 - Congrats to all!

Tranexamic acid is a powerful anti-fibrinolytic that stops bleeding & has been shown to be useful for heavy menstrual bleeding & post-partum hemorrhage. Have you seen this NEW #RPTHIllustratedReview by Nicole Relke, Nick Chornenki, MD 🇺🇦, & Michelle Sholzberg?! #ISTH2021 onlinelibrary.wiley.com/doi/full/10.10…

This week we sort out a 🩸bloody🩸 mess, the mess of anticoagulants that is! Written by Nick Chornenki, MD 🇺🇦 (IM Resident) & reviewed by Dr. Janet Lui (Hematology) & Dr. Marie Leung (GIM), we explore the coagulation cascade, anticoagulant options & work-up required @queensuim

#RPTH Top 10 Altmetric Scores of 2021: No. 1 – all things TRANEXAMIC ACID 🔥 This #RPTHIllustratedReview by Nicole Relke Nick Chornenki, MD 🇺🇦 & Michelle Sholzberg is extremely popular & good for teaching too. Check it out here: onlinelibrary.wiley.com/doi/full/10.10… #TXA Congratulations to all! 🥳

Characterizing #Frailty In Myeloproliferative Neoplasms: results from the #ORCHIDstudy Nick Chornenki, MD 🇺🇦 Deborah Siegal Darryl Leong Chris Hillis sciencedirect.com/science/articl… #LeukemiaResearch Journal

Missing Keshi Kiruba and @Oh__G on their well deserved vacation!

Confused about coagulation testing? Check out our article on INR and aPTT testing. Michelle Sholzberg Michael Fralick cmaj.ca/content/194/33…

If you ever request INR or APTT, this is for you. An one page summary of the key points published today by the CMAJ. Although the authors are Canadian, the points made apply internationally. tinyurl.com/33f82nud

This stinks

The best co-residents!

🩸How serious are major gastrointestinal bleeds on DOACs? Looking forward to this SR/MA of Nick Chornenki, MD 🇺🇦 Deborah Siegal and team on all-cause mortality after major GI bleeding. Stay tuned. CanVECTOR Network rdcu.be/c1Gcy

Thank you Geoff Barnes!! 💫❤️💫Nicole Relke Nick Chornenki, MD 🇺🇦 RPTH

Congratulations to so many Ontarians today who are new members of the medical profession getting your acceptance to medical school. For others, it is a hard day. Don't give up. It's worth the efforts. We need you.

Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System ow.ly/7yPV50RJrti #clinicaltrialsandobservations #genetherapy

If we are lucky, we get thoughtful advise from colleagues and mentors that helps us grow. This isn't always the case. Here are the 5 worst pieces of advice I have received in my career. A 🧵 If you are comfortable, please reply with bad advice you have learned so we can all

Have you ever used dual direct oral anticoagulation therapy to treat refractory thrombosis? In this brief report, Nick Chornenki, MD 🇺🇦 et al describe their experience in using dual #DOAC therapy (FXa and FIIa inhibitors) in 8 refractory thrombosis cases! Read rpthjournal.org/article/S2475-…

Congratulations to Nick Chornenki, MD 🇺🇦 on presenting our analysis of older adults who survive hospitalization for OAC related bleeding. High short term mortality, rebleeding, and rehospitalization means we have ++ work to do to improve outcomes!

Evergreen #ASH2024

What a year 2024 in hematology! Here's a thread on selected clinical studies we've seen this year🧵🩸